Evidence map›Paper›PMID 28334044›Full record

ArticlePloS one2017

In vitro and in vivo evaluation of docetaxel-loaded stearic acid-modified Bletilla striata polysaccharide copolymer micelles.

Qingxiang Guan, Guangyuan Zhang, Dandan Sun, Yue Wang, Kun Liu, Miao Wang, Cheng Sun, Zhuo Zhang, Bingjin Li, Jiayin Lv

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Frontiers in immunology · 2024
    Article
  5. Review
  6. Article
  7. Review
  8. Interactions of Self-AssembledPharmaceutics · 2019
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Qingxiang GuanSchool of Pharmacy, Jilin University, Changchun, China.
Guangyuan ZhangSchool of Pharmacy, Jilin University, Changchun, China.
Dandan SunSchool of Pharmacy, Jilin University, Changchun, China.
Yue WangFaculty of Chemistry, Northeast Normal University, Changchun, China.
Kun LiuSchool of Pharmacy, Jilin University, Changchun, China.
Miao WangSchool of Pharmacy, Jilin University, Changchun, China.
Cheng SunSchool of Pharmacy, Jilin University, Changchun, China.
Zhuo ZhangChina-Japan Union Hospital of Jilin University, Changchun, China.
Bingjin LiThe Second Hospital of Jilin University, Changchun, China.
Jiayin LvChina-Japan Union Hospital of Jilin University, Changchun, China.
Jilin University · CNUnion Hospital · CNNortheast Normal University · CNSecond Affiliated Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bletilla striata polysaccharides (BSPs) have been used in pharmaceutical and biomedical industry, the aim of the present study was to explore a BSPs amphiphilic derivative to overcome its application limit as poorly water-soluble drug carriers due to water-soluble polymers. Stearic acid (SA) was selected as a hydrophobic block to modify B. striata polysaccharides (SA-BSPs). Docetaxel (DTX)-loaded SA-BSPs (DTX-SA-BSPs) copolymer micelles were prepared and characterized. The DTX release percentage in vitro and DTX concentration in vivo was carried out by using high performance liquid chromatography. HepG2 and HeLa cells were subjected to MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazonium bromide) assay to evaluate the cell viability. In vitro evaluation of copolymer micelles showed higher drug encapsulation and loading capacity. The release percentage of DTX from DTX-SA-BSPs copolymer micelles and docetaxel injection was 66.93 ± 1.79% and 97.06 ± 1.56% in 2 days, respectively. The DTX-SA-BSPs copolymer micelles exhibited a sustained release of DTX. A 50% increase in growth inhibition was observed for HepG2 cells treated with DTX-SA-BSPs copolymer micelles as compared to those treated with docetaxel injection for 72 h. DTX-SA-BSPs copolymer micelles presented a similar growth inhibition effect on Hela cells. Furthermore, absolute bioavailability of DTX-SA-BSPs copolymer micelles was shown to be 1.39-fold higher than that of docetaxel injection. Therefore, SA-BSPs copolymer micelles may be used as potential biocompatible polymers for cancer chemotherapy.

Indexed as

Antineoplastic AgentsCell Line, TumorDocetaxelDrug CarriersHeLa CellsHep G2 CellsHumansHydrophobic and Hydrophilic InteractionsMicellesPolymersPolysaccharidesSolubilityStearic AcidsTaxoidsAntineoplastic AgentsDocetaxelDrug CarriersMicellesPolymersPolysaccharidesstearic acidStearic AcidsTaxoids

Identifiers

PMID28334044
PMCPMC5363891
OpenAlexW2601197743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.